<SEC-DOCUMENT>0001140361-19-008115-index.html : 20190501 <SEC-HEADER>0001140361-19-008115.hdr.sgml : 20190501 <ACCEPTANCE-DATETIME>20190501083019 ACCESSION NUMBER: 0001140361-19-008115 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20190501 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20190501 DATE AS OF CHANGE: 20190501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 19784908 BUSINESS ADDRESS: STREET 1: 430 E. 29TH STREET STREET 2: 14 FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 430 E. 29TH STREET STREET 2: 14 FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>form8k.htm <DESCRIPTION>CURRENT REPORT <TEXT> Document 1 - file: form8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ex99_1.htm <DESCRIPTION>THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF CELGENE CORPORATION AND RELATED NOTES FOR THE THREE-MONTHS ENDED MARCH 31, 2019. <TEXT> Document 2 - file: ex99_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>3 <FILENAME>ex99_2.htm <DESCRIPTION>UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF BRISTOL-MYERS SQUIBB COMPANY GIVING EFFECT TO THE ACQUISITION OF CELGENE CORPORATION <TEXT> Document 3 - file: ex99_2.htm
</DOCUMENT> </SEC-DOCUMENT>